From Research to Manuscript by Michael Jay Katz

Author:Michael Jay Katz
Language: eng
Format: epub
Publisher: Springer
Published: 2019-05-27T16:00:00+00:00

• From a report on using high doses of cytosine arabinoside (ARA-C) to keep patients with acute myeloid leukemia (AML) in continuous complete remission (CCR) (Bohm et al., 2005):

“3.1. Outcome of induction chemotherapy

“Seventy-three patients with de novo AML received induction treatment with DAV. Complete remission (CR) was obtained in 54/73 patients (74%). The majority of these patients (36/54 = 66.7%) entered CR after the first induction cycle, whereas in 18/54 patients (33.3%), more than one induction chemotherapy cycle (two cycles, n = 15; three cycles, n = 3) was required to achieve a CR. In 19 patients (26%), no CR could be obtained. In this group, 16 patients had blast cell persistence, and three patients died from treatment-related complications within 28 days after start of therapy (induction-related death).”

• From a report on the effects of three natural agonists on the contraction of smooth muscle in lung airways (Perez and Sanderson, 2005): (SMC = smooth muscle cell)

Download

Copyright Disclaimer:
This site does not store any files on its server. We only index and link to content provided by other sites. Please contact the content providers to delete copyright contents if any and email us, we'll remove relevant links or contents immediately.